Is compounded tirzepatide cheaper than Zepbound?

Usually yes on the sticker price: as of November 10, 2026, compounded tirzepatide programs we track charge $129 to $399 a month all-in at 10 mg, while Lilly’s self-pay Zepbound vials cost $299 at 2.5 mg, $399 at 5 mg and $449 to $699 a month from 7.5 mg depending on refill timing. The two are not the same product. Zepbound is FDA-approved; compounded tirzepatide is made with the drug in Zepbound but is not FDA-approved or FDA-reviewed, so the price gap buys a different level of regulatory assurance.